Recurrent Endometrial Undifferentiated Carcinoma

3 clinical trials · Condition

Record	Firm	Date
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612)	National Cancer Institute (NCI)	2019-08-22
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer (NCT03120624)	Mayo Clinic	2017-09-15
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (NCT00492778)	GOG Foundation	2008-02-25

Every clearance here is in the API, with alerts when new ones post.